Keywords: canada, oks, merck, maxalt, health, approved, co

Canada OKs Merck's Maxalt

Article | 16 September 1999

Print This

Health Canada has approved Merck & Co's Maxalt (rizatriptan) forthe treatment of migraine. The product will be available in a tablet ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in